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Labyrinthopeptins are class III lantibiotics produced
by the actinomycete Actinomadura namibiensis. The
most characteristic structural feature is the post-
translationally installed triamino triacid labionin with
a quaternary a-carbon. In addition to the unique
structure, labyrinthopeptin A2 possess remarkable
antiviral and antiallodynic biological activities. To
harness the substrate tolerance of the biosynthetic
machinery, we developed an efficient system for
the generation of labyrinthopeptin analogs. Strepto-
myces lividans was used as a heterologous host
since the natural producer Actinomadura namibien-
sis remained genetically intractable. Generation of
a library of 39 mutants allowed identification of vari-
able and invariable regions in the labyrinthopeptin
structures. Additional data on the flexibility of the
biosynthetic machinery were provided by in vitro
experiments. This study is detailed investigation on
the potential to generate analogs of class III lantibiot-
ics by genetic engineering.
INTRODUCTION
Lantibiotics are ribosomally synthesized peptides that are
subsequently posttranslationally modified by specific enzymes.
A ribosomally synthesized precursor peptide is composed of
two segments. The N-terminal region, termed leader peptide,
is followed by a core peptide that accommodates further struc-
tural modifications. In a first enzymatic step 2,3-didehydroala-
nines (Dha) and/or 2,3-didehydrobutyrines (Dhb) are formed
by dehydrations of Ser or Thr, respectively. In the subsequent
enzymatic step intramolecular Michael-type addition of the thiol
side chain of Cys establishes the lanthionine or methyllanthio-
nine (MeLan) rings (Willey and van der Donk, 2007).
Labyrinthopeptins A1 and A2 (Figure 1) were isolated at Aven-
tis in 1988 from a desert bacterium Actinomadura namibiensis
(Wink et al., 2003), and their structures were elucidated in our
groups only recently by solving the X-ray structure of labyrintho-
peptin A2 (Meindl et al., 2010). The most characteristic feature ofChemistry & Biology 20, 111the labyrinthopeptin structure is a unique posttranslationally
introduced amino acid named labionin (Lab) (Figure 1), a struc-
tural variation of lanthionine. According to the biosynthetic
gene cluster composition and the sequence of precursor
peptides, labyrinthopeptins were classified as class III lantibiot-
ics (Willey et al., 2006). The labyrinthopeptin biosynthetic gene
cluster (lab cluster; size 6.4 kb) encodes only five genes (Meindl
et al., 2010). Genes labA1 and labA2 code for labyrinthopeptin
A1 and A2 precursor peptides (LabA1 and LabA2), containing
a characteristic Ser/Ser/Cys-motif as a Lab precursor. The
gene labKC codes for the tridomain protein LabKC with a Ser/
Thr kinase domain, a lyase domain and a C-terminal putative
cyclase domain. The biosynthesis of labyrinthopeptin A2 was
reconstituted in vitro with heterologously expressed LabKC
and synthetic precursor peptide to yield properly dehydrated
and cyclized peptide (Mu¨ller et al., 2010). The genes labT1 and
labT2 code for ABC transporters with a putative secretion func-
tion. Interestingly, neither extracellular proteases, nor a protease
domain in transporters (labT1 and labT2) could be identified for
a leader peptide cleavage within the borders of the sequenced
cosmid. It has been, however, already reported in the literature
that some lantibiotics rely on nonspecific proteases for a leader
peptide cleavage (Chatterjee et al., 2005; Widdick et al., 2003).
In addition to the unique structure of labyrinthopeptins, it has
been found that, labyrinthopeptin A2 exhibits potent activity in
a spared nerve injury mouse model of neuropathic pain (Meindl
et al., 2010). These properties turn labyrinthopeptins into lead
structures for therapeutic applications. Herein, we present an
in vivo system for the heterologous production of labyrinthopep-
tins, enabling access to novel labyrinthopeptins and harnessing
the flexibility of the biosynthetic machinery. As a total synthesis
of labyrinthopeptin is presumably complex and has not been re-
ported so far (Sambeth and Su¨ssmuth, 2011), the in vivo system
represents an important foundation to elucidate structure-
activity relationships of this class of compounds in future studies.
RESULTS
Heterologous Expression of the Labyrinthopeptin (lab)
Gene Cluster in Streptomyces Host Strains
Mutagenesis of amino acids in the core peptide of labyrintho-
peptins was envisioned to be performed with the native pro-
ducer Actinomadura namibiensis. However, various procedures
of genetic manipulation (e.g., polyethylene glycol-induced–122, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 111
Figure 1. Structures and Biosynthesis of Labyrinthopeptins
(A) Structures and ring assignments of labyrinthopeptin A1 and A2 (leader peptide sequence given as a one-letter code).
(B) Organization of the labyrinthopeptin (lab) gene cluster with genes coding for the structural genes labA1/A2, the modifying enzyme labKC, and transporters
labT1/T2.
(C) Structure of labionin (Lab) and lanthionine (Lan).
(D) Alignment of the core regions of precursor peptides belonging to class III gene clusters with putative ring topologies of labyrinthopeptins (conserved Ser/Ser/
Cys motif is highlighted).
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direct transformation, and conjugation) of Actinomadura
namibiensis failed (unpublished data). It was therefore decided
to attempt the heterologous expression of labyrinthopeptins
in suitable Streptomyces hosts. Consequently, the lab gene
cluster was cloned under the control of the constitutive ermE*
promoter (Wilkinson et al., 2002) into pUWLoriTapra, an
Escherichia coli - Streptomyces shuttle vector (Wehmeier,
1995). The resulting pUWLab vector was subsequently used to
transform five potential Streptomyces host strains: S. albus,
S. avermitilis, S. coelicolor, S. griseus, and S. lividans. These
mutants and parental host strains transformed with an empty
control vector (pUWLoriTapra) were cultured in different pro-
duction media under apramycin selective pressure. For each
strain two types of liquid cultures (YEME or M5294 medium)
and solid agar plates (R2YE, KM4) were prepared. The trans-
formant cultures were screened for labyrinthopeptin production
by means of HPLC-electrospray ionization (ESI)-MS. The chro-
matograms of extracts from S. lividans cultures revealed the
presence of peak signals with retention times Rt = 4.97 and
5.20 min, corresponding to new compounds as compared to
the control strains (Figure 2).
A more detailed analysis using high resolution mass spec-
trometry (MS) (LC-ESI-Orbitrap-MS) revealed that observed
compounds correspond to posttranslationally modified labyrin-
thopeptin A1 and A2 derivatives with the appropriate number
of dehydrations but with additional amino acid attachments
from incomplete leader peptide removal (Table S1 available
online). Apparently, S. lividans/pUWLab was able to express
labyrinthopeptin A1 with an N-terminal Asp (major product;
D-labyrinthopeptin A1) and an N-terminal Ala-Asp (AD-labyrin-112 Chemistry & Biology 20, 111–122, January 24, 2013 ª2013 Elsevthopeptin A1) overhang (Figure 3A). The only observed variant
of labyrinthopeptin A2 contained an N-terminal Asn-Arg over-
hang (NR-labyrinthopeptin A2) (Figure 3A). Correctly processed
labyrinthopeptins were not detected by means of high-perfor-
mance liquid chromatography MS (HPLC-MS). The same results
were observed for S. albus/pUWLab (data not shown). In order to
provide further proof that observed peptides were labyrintho-
peptins with proper ring topologies, tandem MS/MS experi-
ments were performed. The MS/MS spectra (Figure S3) show
that both expressed labyrinthopeptin variants display identical
fragmentation patterns as the wild-type peptides, suggesting
the same ring topology. In contrast, cultures of S. coelicolor,
S. avermitilis, and S. griseus carrying the vector pUWLab did
not show any products corresponding to labyrinthopeptins,
and therefore were not considered for further experiments. Since
the production levels were significantly higher for S. lividans
compared to S. albus, as judged by semiquantitative LC-ESI-
MS, further investigations were performed using S. lividans. A
more thorough investigation confirmed peptide production
under various tested growth conditions: in both liquid cultures
and on solid agar plates. Interestingly, we observed that the ratio
between the derivatives AD- and D-labyrinthopeptin A1 depends
on the cultivation time. In an early growth phase (day 5), AD-
labyrinthopeptin A1 was the main product, which, however,
changed in favor of D-labyrinthopeptin A1 upon further cultiva-
tion (day 14). Prolonged cultivation however did not yield
correctly processed labyrinthopeptins. The data clearly prove
that both labyrinthopeptins can be heterologously expressed in
selected Streptomyces host strains. However, the anticipated
wild-type-like maturation of the peptides was not observed
due to incomplete removal of the leader peptide.ier Ltd All rights reserved
Figure 2. Expression of Labyrinthopeptin Variants in S. lividans
(A) Vector pUWLab used for expression in Streptomyces hosts.
(B) Detection of the labyrinthopeptin derivatives D-, AD-labyrinthopeptin A1, and NR-labyrinthopeptin A2 from liquid cultures of S. lividans/pUWLab (9d, YEME
medium). Total ion chromatogram (TIC, QTrap).
(C) Extracted Ion Chromatogram (EIC, QTrap) over the mass range m/z 1,095.5–1,096.5 corresponding to doubly charged D-labyrinthopeptin A1 and m/z
1,097.5–1,098.5 corresponding to doubly charged NR-labyrinthopeptin A2 (see Table S1). Themolecular masses of labyrinthopeptin A1 and A2 were not found in
the culture filtrates.
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Engineering Platform of Labyrinthopeptin Variants
in S. lividans
The ribosomal origin of lantibiotics turns them into attractive
targets for the generation of novel derivatives through manipu-
lations of the gene encoding a core peptide. In addition to a
broad substrate tolerance of the biosynthetic machinery, an
ideal expression system should contain an easily alterable
structural gene. Following these lines, only a part of the vector
pUWLab coding for the precursor peptides LabA1 and LabA2
needed to be modified. We identified two rarely occurring
restriction sites (PasI and Eco47III), which could be used to
precisely excise a fragment containing the labA1 and labA2
genes (Figure S4A). Since restriction sites for these enzymes
appeared twice in the pUWLab sequence, we removed the
undesiredpair of restriction sitesby silentmutations (FigureS4A).
The advantage of this construct is that the modification of genes
encoding the core peptides is performed on a relatively small
DNA fragment (368 bp) that can be easily replaced in the gene
cluster giving rise to variants. In order to further facilitate an
efficient cloning, we exchanged this fragment with an ampicillin
(Amp) resistance gene yielding the pLabAmp vector (Figure S4B).
This construct has the advantage of eliminating false-positive
clones, resulting from a nondigested vector, by preparation of
ampicillin replica plates. The constructed pLabAmp vector was
used in all following experiments.
Correct Proteolytic Processing of Labyrinthopeptins
by C-Terminal Modifications of the Leader Peptide
A general obstacle of the heterologous expression in S. lividans
was the undesired production of labyrinthopeptin variants with
additional N-terminal amino acids. These overhangs could
potentially alter biological activity and the presence of mixturesChemistry & Biology 20, 111of differently processed peptides imposes significant problems
in the purification. To overcome this limitation, we sought to
mutagenize the 1 position of the leader peptide directly adja-
cent to the core peptide. We decided to introduce Met between
leader and core peptide to enable a subsequent chemical
cleavage of the leader overhang with CNBr (Kaiser and Metzka,
1999). To express labyrinthopeptins with additional Met,
a synthetic gene (SG2) was constructed (Figure 3). In the labA1
gene the codon for the Asp-1 residue of the leader peptide
was replaced with the Met codon, while in the labA2 gene the
Met codon was inserted between Arg-1 of the leader and Ser1
of the core peptide (Figure 3). After transformation and growth
of the corresponding strain (S. lividans/pLab_SG2) for 5 days,
culture filtrates were analyzed by HPLC-ESI-MS. From the set
of labyrinthopeptin A1 derivatives, three peptides AM-, M-, and
also labyrinthopeptin A1 were detected (Figure 3). Interestingly,
no expression of labyrinthopeptin A2 was observed. The
HPLC-ESI-MS analysis of older cultures (16 days) showed that
almost all AM- and M-labyrinthopeptin A1 was converted into
labyrinthopeptin A1 (Figure S1). While Met substitution led to
a correctly processed peptide, it seemed that Met insertion
into the labyrinthopeptin A2 leader completely abolished the
expression. Therefore, use of pLab_SG2 allows for the sole
expression of labyrinthopeptin A1 in S. lividans, thus facilitating
the isolation of this peptide due to the absence of labyrinthopep-
tin A2. This construct was further used for generation of most of
the presented labyrinthopeptin A1 derivatives. In order to eval-
uate whether the above-mentioned genetic modifications in
the leader peptide had an influence on the formation of labionin,
we employed a previously described gas chromatography (GC)-
MS method (Pesic et al., 2011). Performed analysis confirmed
the presence of labionin in the labyrinthopeptin A1 isolated
from S. lividans/pLab_SG2 (Figure S5).–122, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 113
Figure 3. Engineering Studies on the Leader Peptide toward Proper Processing by the Proteolytic System of S. lividans
Schematic representations of precursor peptide genes and corresponding product detection by LC-ESI-Orbitrap-MS.
(A) S. lividans/pLab producing AD-, D-labyrinthopeptin A1, and NR-labyrinthopeptin A2.
(B) S. lividans/pLab_SG2 producing labyrinthopeptin A1 and M-labyrinthopeptin A1 (see also Figures S1, S3, and S4).
(C) S. lividans/pLab_SG6 producing AM-, M-, and labyrinthopeptin A2 and ENR-, NR-, and R-labyrinthopeptin A1 (Figures S2 and S3).
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to establish a proper processing of labyrinthopeptin A2. A
construct pLab_SG6was prepared that contained a gene coding
for LabA2 with the leader peptide derived from LabA1 (used in
construct pLab_SG2) (Figure 3). In addition the order of both
structural genes was exchanged (from labA1/labA2 into labA2/
labA1). This modification was justified by the observation that
production levels might be influenced by the gene order as
labyrinthopeptin A1 is produced in higher yields in both, wild-
type producer and heterologous host (approximately 2-fold).
The resulting mutant S. lividans/pLab_SG6 expressed labyrin-
thopeptin A2 without amino acid overhangs (Figures 3 and S2).
Construct pLab_SG6 was therefore used for the generation of114 Chemistry & Biology 20, 111–122, January 24, 2013 ª2013 Elsevnearly all subsequent labyrinthopeptin A2 derivatives. The
production levels in 16 days old cultures determined by HPLC-
ESI-MS for both constructs pLab_SG2 (86 mg/l for labyrintho-
peptin A1) and pLab_SG6 (14 mg/l for labyrinthopeptin
A2) were found to be well in the range of the wild-type
A. namibiensis (90 and 39 mg/l for labyrinthopeptin A1 and A2,
respectively).
Construction of an Ala-scan Mutant Library of LabA1
and LabA2 Peptides
Structure-activity relationship (SAR) studies assess the impor-
tance and contribution of different parts of a molecule to its
bioactivity. One of the most widely used strategies for SARier Ltd All rights reserved
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which single amino acid residues are systematically replaced
with alanine (Lefe`vre et al., 1997). Herein, we report on the Ala-
scan experiment performed on labyrinthopeptins A1 and A2,
allowing the assessment of the substrate tolerance and flexibility
of the biosynthetic machinery.
Nine mutants were generated for each peptide, LabA1 and
LabA2, keeping amino acid residues involved in Lab formation
mainly unmodified. In each case, the presence of peptides in
extracts from cultures was verified by HPLC-ESI-Orbitrap-MS.
Interestingly, LabA1 and LabA2 mutants displayed considerable
differences in productions levels of labyrinthopeptins in liquid
cultures as judged by semiquantitative HPLC-ESI-MS (Figure 4).
For all Ala exchange mutants production levels were lower
as compared to unmodified peptides expressed in S. lividans.
Molecular masses corresponding to labyrinthopeptin A1
mutants were found in all three tested media (YEME, R2YE, NZ
Amine) (Table S2). In contrast, labyrinthopeptin A2 mutants
were produced in reasonable amounts only in NZ Amine
medium. For all detected peptides the molecular masses from
high resolution HPLC-ESI-MS were in agreement with the
calculated molecular masses (Table S2). Interestingly, a clear
trend in production decrease could be observed when replacing
aromatic amino acids (Trp or Phe) with Ala. Following these
lines, we generated one LabA1 mutant with a Trp/ Tyr substi-
tution (LabA1_W6Y) to maintain the aromatic character of the
substituent. This mutant peptide was produced in significantly
higher yields than the corresponding alanine-exchange mutant
(LabA1_W6A).
Modulation of the Labyrinthopeptin Structure by Ring
Expansion and Ring Contraction Approaches
To explore the possibility of performing rational modifications of
the labyrinthopeptin structure, we probed the tolerance of the
biosynthetic machinery to more drastic structural changes. The
alignment of LabA2 with core peptides from homologous gene
clusters (Figure 1D) reveals a characteristic Ser-(Xxx)2-Ser-
(Xxx)n-Cys motif, implying a conserved structural framework
for class III lantibiotics. Hence, putative labyrinthopeptin-like
peptides apparently should contain conserved A/A0 rings,
whereas the sizes of the putative B and B0 rings are variable.
We therefore investigated to which extent these rings sizes could
be varied in S. lividans.
To verify if the A and A0 rings are amenable to ring contractions
or expansions, six different LabA1 variants were realized. To
increase ring sizes, amino acids Asp, Asn were inserted at two
different positions of the A ring (LabA1_N2insD, LabA1_N2insN),
and one amino acid (Ala) at a single position of the A0 ring
(LabA1_G12insA) (Figure 4; Table S2). In order to decrease
A/A0 ring sizes, Ala and Gly were removed (LabA1_A3 del,
LabA1_G12 del) (Figure 4; Table S2). As a result, none of the
expected peptides was detected in bacterial cultures of the six
S. lividans mutants, as evaluated by means of HPLC-MS
analysis.
To assess the flexibility of the biosynthetic machinery for vari-
ations of the B ring size, two B ring and three B0 ring mutants
were generated for LabA1 in S. lividans. The ring expansion
was assessed by insertion of an additional Val (LabA1_W6insV,
LabA1_P16insV). In order to decrease the size of the B ring,Chemistry & Biology 20, 111Val or Pro were removed (LabA1_V5 del, LabA1_P16 del) (Fig-
ure 4; Table S2). In contrast to the A ring mutants, for all B ring
mutants the expected product masses in the culture filtrates
were found (Table S2). Hence, labyrinthopeptin A1 variants
bearing a tetra- (LabA1_V5 del), penta- (LabA1), and hexapep-
tide (LabA1_W6insV) in their B rings were detected by HPLC-
MS. Likewise the B0 ring may constitute a penta- (LabA2),
hexa- (LabA1_P16 del), hepta- (LabA1), and octapeptide
(LabA1_P16insV). The proper ring topology in expressed mu-
tants was confirmed by MS/MS experiments (Figure S7).
In addition, we succeeded in a more vigorous alteration of
the architecture by swapping the A0B0 rings between LabA1
and LabA2 i.e., to obtain hybrid peptides ABLabA1A
0B0LabA2 and
ABLabA2A
0B0LabA1 (Figure 4). Corresponding constructs were
prepared as a synthetic gene SG11 (Table S2).
Structural Modifications of the Labionin Framework
and the C Ring
In a third round of mutagenesis experiments, we sought to
perform even more basic changes affecting labyrinthopeptin
A1 ring integrity. For this purpose, Ser residues were substituted
with Ala to verify whether labionin rings could be exchanged to
lanthionine rings of the same size (Figure 4). The Ser/Ala
substitutions at either position 4 or 13 could result in establish-
ment of Lan-bridges between Ser1 and Cys8, and Ser10 and
Cys19, respectively. However, expression of the corresponding
labyrinthopeptin A1 mutants S4A and S13A was not observed,
indicating that the biosynthetic machinery is sensitive to
changes of the labionin scaffold. We then assessed the posi-
tional flexibility of the C ring. The corresponding mutants were
generated by site-directed mutagenesis with the vector
pMK_SG2 as a template (Table S5). The production of labyrin-
thopeptin A1 by C20 del mutant (Figure 4; Table S2) shows
that the disulfide bridge is not required for production of
labyrinthopeptin A1 derivatives. Likewise the S1insC/C20 del
mutant peptide (Figure 4; Table S2) proves the possibility to
swap a disulfide bridge from the C- to the N-terminal part of
the molecule. In this case, occurrence of the disulfide bond
was deduced based on the observed molecular mass
clearly indicating cystine formation (2 Da = 2H). Mutants
LabA1_S10insA and LabA1_C20insA show that the size of ring
C can be increased although the production levels of these
variants were significantly lower, as judged by HPLC-ESI-MS.
As various class III precursor peptides indicated variable
distances between putative AB and A0B0 ring systems, we
wanted to evaluate whether there exists any structural flexibility
in this region for labyrinthopeptins (Figure 1D). This region, which
harbors up to five amino acids, is therefore termed a spacer
peptide. Hence, the corresponding mutants LabA1_C9insV
and LabA1_C9insVN were generated. No production was
observed for these mutants, suggesting that the region between
rings B and C could not be extended by additional amino acids.
Finally, with respect to the large molecular mass of labyrintho-
peptins (2 kDa), it was attempted to reduce the molecular
size by expression of partial constructs (Figure S6). Such a
construct, LabA1_west, was generated by introducing a stop
codon C-terminally of Cys8 by site-directed mutagenesis. The
experiment was performed with pMK_SG2 as a template. To
express LabA1_east, a synthetic gene SG7 was used. However,–122, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 115
Figure 4. Labyrinthopeptin Mutants Expressed in S. lividans
(A) Concept of performed modifications (for cloning strategy, see Figure S5 and Tables S3 and S4).
(B) Overview of Ala exchangemutagenesis performed on LabA1 and LabA2. Observed production levels are represented (gray, >5mg/l; white, <5mg/l; white with
dotted line, no production).
(C) Overview of preparedmutants (see also Figure S6). Expression of the peptide was evaluated by high-resolving HPLC-MS (detectedmutantsmarked with tick,
mutants not detected marked with cross; see Table S2 for observed masses and Figure S7 for MS/MS spectra).
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Table 1. Comparison of In Vitro—LabKC Assay—and In Vivo
Processing of Selected LabA1 Mutant Peptides
Peptide Modification In Vivo
In Vitro
Final
Product
Inter-
mediates
LabA1a wild-type + + 
LabA1_N2insA A ring expansion  + 
LabA1_A3 del A ring contraction  + +
LabA1_G12 del A0 ring contraction   +
LabA1_C9insV spacer peptide
expansion
  +
LabA1_west C-terminal truncation   +
LabA1_east N-terminal truncation  + +
LabA1_S1A lanthionine variant N/A + 
LabA1_S4A lanthionine variant  + 
LabA1_S10A lanthionine variant N/A + +
LabA1_S13A lanthionine variant  + +
In vitro processing was assessed based on observed dehydrations; in
addition to fully dehydrated peptide, accumulation of intermediates is
also indicated (see Figures S8–S10). N/A, not applicable.
aPrecursor peptide sequence as in SG2 construct.
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cultures.
In Vitro Substrate Tolerance of the Modifying Enzyme
LabKC
Above presented engineering studies were restricted to heterol-
ogously expressed labyrinthopeptins from S. lividans. However,
to better understand the observed restrictions on the structural
manipulations, we decided to evaluate the tolerance of the
modifying enzyme LabKC in vitro. As it was stated previously
a number of factors, i.e., expression, posttranslational modifi-
cations, secretion or stability, may contribute to the negative
outcome of in vivo expression of ribosomally synthesized
peptides (Chatterjee et al., 2006). Therefore, we focused our
efforts on reconstituting the biosynthesis of labyrinthopeptin
A1 analogs with synthetic peptides and heterologously ex-
pressed LabKC. We decided to choose the mutants bearing
significant structural alterations that were not produced in vivo.
An assessment of enzymatic conversion was based on the
extent of phosphorylations and/or dehydrations as summarized
in Table 1. For three mutants (LabA1_G12 del, LabA1_west and
LabA1_C9insV), fully dehydrated products were not detected
under assay conditions (Figure 5). Two A/A0 ring mutants
(LabA1_A3 del and LabA1_G12 del) showed hampered dehydra-
tions upon decreasing the A/A0 ring size (Figure 5). Interestingly
the A ring insertion mutant (LabA1_N2insA) was processed as
efficiently as the LabA1 peptide (Figure 5). However, MS/MS
experiment for processed LabA1_N2insA peptide indicated
that the expansion of the A ring allowed for dehydration reactions
but impaired cyclization (Figure S9). In addition to the in vivo data
on the LabA1_S4A and LabA1_S13A mutants, we evaluated the
possibility of Lab/Lan transformations. All four tested S/A
mutant peptides (LabA1_S1A, LabA1_S4A, LabA1_S10A, and
LabA1_S13A) were dehydrated (Figure S8); however, manipula-
tions in the C-terminal Lab impaired dehydration activity and ledChemistry & Biology 20, 111to accumulation of phosphorylated intermediates (Figure S8).
Further MS/MS analysis revealed that the LabA1_S1A peptide
contains possibly a Lan ring, whereas peptide Lab_S4A did not
contain any ring in the N-terminal region (Figure S9). Altogether
the in vitro data suggest that abolished in vivo production of
tested mutants could be explained either by an impaired dehy-
dration activity of the modifying enzyme (peptides: LabA1_A3
del, LabA1_G12 del, LabA1_C9insV, LabA1_west, LabA1_east,
LabA1_S4A, LabA1_S13A) or impaired cyclization activity
(peptides: LabA1_N2insA, LabA1_S4A). Interestingly, data
suggest that processing by LabKC is more sensitive to manipu-
lations in the C-terminal part. These results are in agreement
with the recent study on new class III lantibiotic catenulipeptin
(Wang and van der Donk, 2012). It was suggested that cycliza-
tion reaction proceeds from C to N terminus and that disruption
of C-terminal labionin also suppressed the formation of
N-terminal labionin. The same directionality of the processing
was also demonstrated by studies on the dehydration of
LabA2 by LabKC (Krawczyk et al., 2012).
DISCUSSION
In recent years, ribosomally synthesized peptides with biological
activities have drawn increasing attention of researchers world-
wide (Hancock and Chapple, 1999; Papagianni, 2003). An
important aspect of this growing interest is the potential for an
engineering of these peptides by alterations of the gene
sequence of precursor peptides. This can facilitate the genera-
tion of a great number and variety of derivatives with structural
features not easily accessible by chemical synthesis. In the
case of lantibiotics, it has been previously shown both in vitro
and in vivo, that there exists a considerable promiscuity toward
precursor peptides that can undergo modifications (Chatterjee
et al., 2006; Zhang and van der Donk, 2007; Levengood et al.,
2009; Caetano et al., 2011). This has not yet been investigated
for class III lantibiotics. In this respect, the recently described
labyrinthopeptins are interesting model compounds due to
their remarkable activity against retroviruses and neuropathic
pain (Meindl et al., 2010). The herein presented results represent,
to our knowledge, the first engineering study of class III lantibiot-
ics. Since attempts to establish a suited genetic system in
the wild-type producer Actinomadura namibiensis failed, we
focused on the expression of labyrinthopeptins in a heterologous
Streptomyces host. Such approach seemed reasonable due to
a manageable size of the biosynthetic gene cluster (6.4 kbp)
and the lack of strong antibacterial activities, which probably
would have required additional factors to establish an intrinsic
resistance. Accordingly, the lab gene cluster was cloned into
the vector pUWL under the control of the constitutive ermE*
promoter and successfully transformed into various Strepto-
myces host strains. Production of labyrinthopeptins was
observed in two different hosts, i.e., S. lividans and S. albus.
This observation suggests that despite the ability of Strepto-
myces hosts to accept a biosynthetic gene cluster from a more
distantly related species, the success of a heterologous ex-
pression is still not predictable.
The initial characterization of transformed mutants carrying
the lab gene cluster did not indicate the presence of labyrintho-
peptins. Only a more detailed analysis using high-resolution–122, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 117
Figure 5. LC-ESI-MS Spectra of In Vitro Conversion of Selected LabA1 Mutants
Comparison of unmodified peptide (upper spectra) and processed peptide (lower spectra). Full processing is represented by the LabA1 peptide and
LabA1_N2insA, whereas processing of other peptides results in accumulation of intermediates (indicated masses correspond to most abundant species).
See also Figures S8–S10).
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with the appropriate number of dehydrations, but with a differ-
ently processed leader peptide. The lack of a corresponding118 Chemistry & Biology 20, 111–122, January 24, 2013 ª2013 Elsevprotease in the lab gene cluster and its up- and downstream
(Meindl et al., 2010) regions suggests that the leader peptide
removal depends on one or several proteases located elsewhereier Ltd All rights reserved
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namibiensis. For class I (subtilin; Klein et al., 1992; Corvey
et al., 2003) and class II lantibiotics (cinnamycin; Widdick et al.,
2003), it has been suggested that unspecific host proteases
might be involved in a lantibiotic maturation process (Chatterjee
et al., 2005). Our data indicate that proteolytic systems of
both S. lividans and S. albus are able to process labyrinthopeptin
leader peptides, however to a different extent and specificity as
compared to the wild-type producer.
In order to prove the presence and topology of labionin rings,
both labyrinthopeptins were analyzed by MS/MS experiments.
The fragmentation pattern of heterologously expressed labyrin-
thopeptin A1 and A2 supports formation of correct ring
systems. Altogether the data demonstrate that it is possible
to produce labyrinthopeptins in S. lividans and S. albus. Among
reports on heterologous expression of lantibiotics, two class II
lantibiotics (i.e., actagardine [Boakes et al., 2009] and cinnamy-
cin [Widdick et al., 2003]) were heterologously expressed in
S. lividans.
Leader peptides of lantibiotics very often have regulatory
functions, preventing the activation of the peptide before full
processing and/or secretion (Oman and van der Donk, 2010).
One significant drawback of the initial expression system pre-
sented here was the incomplete removal of the leader peptide.
In order to overcome this problem, we decided to engineer the
leader peptide, This approach was supported by in vitro experi-
ments on class III lantibiotics that demonstrated that the
C-terminal part of the leader peptide of LabA2 serves as a spacer
and does not play an important role in the processing by the
modifying enzyme LabKC (Mu¨ller et al., 2011). Following this
line we decided to incorporate Met at position 1 of the leader
in order to have the fall back option for a chemical CNBr
cleavage. However, insertion of Met in the case of LabA2 fully
abolished production. While this finding indicates significant
differences between the in vitro and in vivo situation, the N(1)
M substitution in the leader peptide of LabA1 allowed production
of properly processed labyrinthopeptin A1. Likewise, the same
approach was successfully used for the production of labyrin-
thopeptin A2. Based on our findings, we suggest that the final
degradation of the leader peptide is accomplished by yet
unknown aminopeptidases of the host strains. In this case,
neutral amino acid side chains at the N termini as present in
peptides M-labyrinthopeptin A2 and NM-labyrinthopeptin A2
appear to be better substrates than charged amino acid side
chains as in D-labyrinthopeptin A1 or NR-labyrinthopeptin A2.
We also observed that the stepwise conversion AM-labyrintho-
peptin A1/M-labyrinthopeptin A1/ labyrinthopeptin A1 (Fig-
ure S1) took several days, which further support arguments for
a nonspecific processing by aminopeptidases. In addition, we
confirmed that Lab formation is not altered by the Met substitu-
tion. To our knowledge, this is the first report of a successful
heterologous production of ribosomally synthesized and post-
translationally modified peptides accomplished by the optimiza-
tion of the leader peptide sequence.
To facilitate engineering studies of labyrinthopeptins, we
established a system for the robust generation of derivatives.
We designed a pLabAmp vector in which cassettes containing
mutated structural genes can be easily inserted. Using this
construct, we performed a partial Ala-scan covering 9 mutantsChemistry & Biology 20, 111for both, LabA1 and LabA2, at positions not directly involved in
Lab formation. For all but one of these Ala-exchanges, we could
detect production of the corresponding peptides. The varying
product yields point to the importance of aromatic amino acids
at distinct positions of the core peptide for processing and/or
export by the biosynthetic machinery. The strongest influence
on the biosynthesis was observed for the Lab_W14A mutant, re-
sulting in abolished labyrinthopeptin production. Similar effects
have been described for lacticin 3147, in which replacements
of aromatic residues with Ala abolished peptide production
(Cotter et al., 2006). The substitution of an aromatic amino
acid by Ala apparently constitutes a considerable change in
terms of steric and electronic demand, and the replacement
with an alternative aromatic amino acid, as exemplified by the
LabA1_W6Y mutant, had a reduced influence on the production
yields. Altogether, the principal feasibility to produce almost all
Ala-scan mutants indicates a great flexibility of the biosynthetic
machinery, thus turning the labyrinthopeptins into good targets
for further engineering studies.
Previous studies on class I and II lantibiotics showed that
the production levels of mutants were significantly reduced or
even totally suppressed if residues involved in lanthionine
formation were modified (Cotter et al., 2006). Our experiments
on substitutions of Ser residues (LabA1_S4A and LabA1_S13A)
in the conserved Ser/Ser/Cys motif led to the full suppression
of production, suggesting that substitutions of Lab with Lan
ring of the same size is not possible and that these rings are
critical for the production. Further investigations carried
in vitro demonstrated that LabA1_S4A mutant can be fully
dehydrated by modifying enzyme but Lan formation in the
N-terminal part was not observed (Figures S8 and S9). Interest-
ingly, any disruption of the C-terminal labionin scaffold has
a negative effect on the dehydration activity of the LabKC
enzyme as demonstrated by LabA1_S10A and LabA_S13A
mutants (Figure S9).
Encouraged by the outcome of the Ala-scan experiments, we
exploited the tolerance of the biosynthetic machinery toward
different ring sizes. It was shown that size of carbacyclic A/A0
rings cannot be changed in vivo. We hypothesize such changes
might have a negative impact on the ability of the peptide to
adopt a conformation providing a proper orientation of all three
amino acid residues involved in Lab formation. Consequently,
suppressed labionin formation could ultimately lead to a rapid
proteolytic degradation of the peptide. To evaluate if these
mutations affect formation of the labionin, the biosynthesis of
the three A/A0 ring mutants (LabA1_N2insA, LabA1_A3 del
and LabA1_G12 del) was subsequently tested in vitro. Our
data suggest that A ring expansion affects the cyclization
whereas A ring contractions can influence the efficiency of
dehydrations carried by LabKC (Figures 5). It is also noteworthy
to underline the advantage of in vitro studies performed in
parallel, which allowed for a better understanding of encoun-
tered difficulties. The restrictions imposed to A/A0 ring varia-
tions are contrasted by the remarkable tolerance to alterations
of the B and B0 ring sizes. It is possible to generate labyrintho-
peptins with tetra-, penta-, hexa-, hepta-, and octapeptide B
ring structures. In addition, mutagenesis of the spacer region
between C and A0 rings revealed that this region also can be
used as a target for engineering. The only invariant part was–122, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 119
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demonstrated that this might be due to decreased dehydration
efficiency as demonstrated for mutant LabA1_C9insV (Figure 5).
Interestingly, it was also possible to remove the disulfide
bridge (C ring) and to introduce a new disulfide bridge to the
N-terminal part of the molecule. According to our results, the
biosynthetic machinery of the lab gene cluster displays a
remarkable tolerance not only to single amino acid substitu-
tions, but also to a variety of ring alterations. Such variations
offer chances for additional structural and conformational
modifications, which is important for future engineering and
bioactivity profiling.
In summary, an efficient heterologous labyrinthopeptin
expression system for performing versatile in vivo engineering
studies was developed. The leader peptide was modified to
facilitate its proper removal by the native host protease system.
In addition, we identified multiple sites in labyrinthopeptins
that can be structurally modified for further SAR studies. In vivo
data were further supplemented with in vitro results allowing
deeper understanding of the encountered limitations of
S. lividans system. The availability of a convenient genetic engi-
neering system enhances the potential of labyrinthopeptins
as novel lead structures for antipain or antiviral therapies.SIGNIFICANCE
Class III lantibiotics represent a structurally and biosynthet-
ically interesting group of ribosomally synthesized peptides.
In addition the remarkable activities of labyrinthopeptins
A1 and A2 turn them into candidates for further drug devel-
opment studies and triggered investigations of their bio-
synthesis. This study reports an in vivo engineering of these
class III lantibiotics in a heterologous host. An important
aspect of this work is the design of a leader peptide, which
allowed for a correct proteolytic processing of labyrintho-
peptins in Streptomyces lividans. The heterologous expres-
sion enabled the production of labyrinthopeptins in amounts
comparable to the wild-type producer, thereby overcoming
an often-encountered practical limitation in many genetic
engineering studies on natural products. The study gives
an overview of the remarkable substrate tolerance of the
biosynthetic machinery for class III lantibiotics comprising
Ala-scan mutagenesis and more challenging variations of
the structural topology.EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
E. coli strains were grown in LB medium supplemented with appropriate
antibiotics at the following concentrations: 50 mg/ml for kanamycin,
100 mg/ml for ampicillin, and 100 mg/ml for apramycin (Apra). The cultures
were incubated at 37C with shaking at 160 rpm. Streptomyces strains were
grown on different agar media (like MS, R2YE, R5, KM4) (Kieser et al., 2000)
at 28C and in liquid media (YEME, CRM, KM4, M5294, NZ-Amine) at 28C
shaking at 160 rpm. Bacterial culture (50 ml) was cultivated in 250 or 300 ml
flask with a coil for a better aeration. Streptomyces containing recombinant
plasmids were grown in presence of apramycin (25 mg/ml or 50 mg/ml).
Following bacterial strains were used: E. coli DH5a, E. coli ET12567,
S. albus CB89 (Combinature Biopharm AG, Berlin, Germany), S. avermitilis
DSM 46492 (DSMZ, Braunschweig, Germany), S. lividans ZX7 (Combinature120 Chemistry & Biology 20, 111–122, January 24, 2013 ª2013 ElsevBiopharm AG, Berlin), S. griseus DSM 40236 (DSMZ, Braunschweig),
S. coelicolor M145 (John Innes Centre, Norwich, UK).
Preparation of a Heterologous Expression System of the Lab Gene
Cluster
All restriction enzymes used in this work were purchased from Fermentas
(Sankt Leon-Rot, Germany). Standard molecular biology methods were used
according to Sambrook andRussell (2001) and are not described here in detail.
The complete lab gene cluster was amplified from cosmid 1104 (Meindl et al.,
2010) by means of PCR (lab_fw: GCGCCGAATTCTTGGAGGAGTGGATGG
ATCTG, GAATTC-EcoRI, GGAGG-RBS and lab_rv GAACCTCTAGACTGA
GCGGCTACC, TCTAGA-XbaI) using Herculase-II-Fusion-DNA polymerase
(for reaction conditions see Table S5). Obtained PCR product (6.4 kb) was
digestedwith restriction enzymes EcoRI and XbaI and cloned under the control
of the constitutive ermE* promoter (Wilkinson et al., 2002) into an Escherichia
coli-Streptomyces shuttle vector pUWLoriTapra (Combinature Biopharm,
Berlin, Germany), yielding the vector pUWLab (13.8 kb). Correctness of the
construct was confirmed by restriction digestion and sequencing reactions
(primers: IkoRev1, LabKC_Fw2, LabKC_Fw3, LabKC_Fw4, LabKC_Fw5,
LabKC_Fw6, IkoRev30, IkoRev40, IkoFw40; Table S3). Subsequently, plasmid
pUWLab was transformed into nonmethylating E. coli strain ET12567/
pUZ8002. Finally, the desired construct was successfully transformed into
five Streptomyces hosts (S. coelicolor M145, S. lividans ZX7, S. albus CB 89,
S. avermitilis DSM 46492, S. griseus DSM 40236) by conjugation.
Plasmids, Oligonucleotides, Synthetic Genes,
and DNA Manipulations
All primers used in this work were purchased from Biomers (Ulm, Germany),
synthetic nucleotides cloned to pMK vector were purchased from GeneArt
(Regensburg, Germany). Sequences of oligonucleotides and synthetic genes
are provided in the Supplemental Information (primers in Table S3 and
synthetic genes in Table S4). All synthetic genes as well as constructs after
site-directed mutagenesis (described bellow) were amplified by PCR (Table
S5) and cloned to pLab or pLabAmp vector digested with PasI and Eco47III
using In Fusion HD Cloning System (Clontech Laboratories, a Takara Bio
Company, Madison, WI) following manufacturer recommendations. PCRs
were performed using Herculase-II-Fusion-DNA polymerase (Agilent Technol-
ogies, Waldbronn, Germany) with primers Infusion1(fw) and Infusion2 (rev,
SG2, SG7) and Infusion3 (rev, SG6, SG11) (Table S3). Standard molecular
biology methods were used according to Sambrook and Russell et al. (2001)
and are not described here in detail.
Site-Directed Mutagenesis
For site-directed mutagenesis experiments, a procedure described by Wang
and Malcolm (1999), which is a slightly modified QuickChange Site-Directed
Mutagenesis System (QCM) developed by Stratagene (La Jolla, CA, USA),
was used. The primers were designed with the program PrimerX (http://
www.bioinformatics.org/primerx). As a template for site-directed mutagen-
esis, pMK vectors containing labA1/2 genes were used (pMK_SG2 for
LabA1 mutants and pMK_SG6 for LabA2 mutants). The procedure consisted
of two stages. In stage one, two extension reactions (Table S5, first PCR)
were performed in separate tubes, each reaction mixture contain only one
primer. Subsequently, the two reactions were mixed, 1 ml of polymerase was
added and another PCR was carried out (Table S5, second PCR). Following
the PCR, 1 ml of DpnI enzyme was added and reaction mixture was incubated
at 37C for 1 hr. The final PCR product (1 ml) was used to transform 100 ml
of E. coli DH5a cells. After plasmid isolation and sequencing the cassette
containing labA1 and labA2 genes was amplified and cloned into pLabAmp
vector as described above.
Sample Preparation for HPLC-ESI-MS Analysis
For bacteria that were grown on solid media, a small piece of an agar was cut
off (around 1 cm2) and extracted with 500 ml MeOH or MeOH: acetone (1:1) by
sonication for 30 min. Later a sample was centrifuged and a soluble fraction
was used for HPLC-ESI-MS analysis. For bacteria growing in a liquid medium,
the first step was separation of bacterial cells from a supernatant. Either the
supernatant was directly used for MS measurements or it was diluted before
in MeOH (1:1).ier Ltd All rights reserved
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Labyrinthopeptins and Their Derivatives by Mass Spectrometry
Labyrinthopeptins were detected by the use of HPLC-ESI-MS. Most of
the presented data were acquired using Agilent 1200 HPLC System (Agilent
Technologies, Waldbronn, Germany) coupled to LTQ-Orbitrap XL (Thermo
Fisher Scientific, Bremen, Germany). Chromatographic separation was per-
formed using reversed phase C18 column GromSil 120 ODS-5 ST (100 3
2.0 mm, Grace, Deerfield, IL) with the mobile phase composed of water (A),
and acetonitrile (B), supplemented with 0.1% formic acid. Gradient from 5%
to 100% of B in 18 min was used. All LC-MS measurements were carried
out in positive-ionization mode. TandemMS/MS experiments were performed
using the same setup and gradient. To obtain better fragmentation, a disulfide
bridge (i.e., ring C) was reduced. Sample was alkalized with NaOH and
incubated with 30 mM DTT for 1 hr prior measurement. Fragmentation was
performed in HCD cell using normalized collision energy of 25%, spectra
were recorded in FTMS mode at resolving power of 7,500.
The above-described HPLC-ESI-MS systemwas also used for extracted ion
chromatogram-based semiquantification. The linear standard curves were
prepared using purified LabA1 and LabA2 isolated from A. namibiensis (Meindl
et al., 2010).
Alternatively for analysis of liquid cultures we used QTrap 2000 (Applied
Biosystems, Darmstadt, Germany) mass spectrometer coupled with Agilent
1100 HPLC. Chromatographic separation was performed on reversed phase
C18 column Luna 3u C18(2) 100 A˚ 50 3 1 mm using gradient from 5% to
100% of B in 10 min.
GC-MS Analysis
The freeze-dried supernatant from liquid culture of S. lividans/pLab_SG2 was
resolubilized in water and subjected to purification by C18 RP Solid Phase
Extraction (MACHEREY-NAGEL). A step gradient elution was used with
mobile phase composed of water and increasing acetonitrile concentration
(from 0% to 100% with 10% increments). Fractions containing labyrintho-
peptin A1 were identified by LC-ESI-MS and subjected to further analysis.
The total hydrolysis, derivatization and GC-MS experiments were carried as
described previously (Pesic et al., 2011).
In Vitro Biosynthesis of Labyrinthopeptin A1 Mutants
The expression, purification and activity assay of the His6-LabKC enzyme with
synthetic precursor peptides was carried as described previously (Mu¨ller et al.,
2011; Krawczyk et al., 2012). Enzyme LabKC (1 mM) was incubated with
precursor peptide (6 mM), GTP (3 mM), and MgCl2 (10 mM) in 20 mM MOPS
buffer (pH 7.0) at 28C for 1 hr. The reaction was quenched with methanol
(1:1, v/v) and subjected to LC-ESI-MS (Orbitrap) analysis. For MS/MS analysis
leader peptide was removed by trypsin (New England Biolabs) addition and
incubation for additional 3 hr followed by MS analytics.
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